Related Experiment Videos
Classification and immunophenotyping of acute leukemias: a prospective study
1Department of Pathology, Aga Khan University Hospital, Karachi.
JPMA. the Journal of the Pakistan Medical Association
|April 1, 1997
Summary
Immunohistochemical analysis of 86 acute leukemia cases revealed distinct immunophenotypes. This study differentiates subtypes of acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) using specific antibodies.
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- Acute leukemia diagnosis relies on morphology and immunophenotyping.
- Immunohistochemistry (IHC) provides detailed cellular marker information.
- Distinguishing subtypes of acute leukemia is crucial for treatment and prognosis.
Purpose of the Study:
- To classify 86 acute leukemia cases using IHC.
- To determine the immunophenotypic profiles of different leukemia subtypes.
- To correlate immunophenotype with patient age and clinical presentation.
Main Methods:
- Analysis of 86 peripheral blood and bone marrow samples over 3.5 years.
- Use of ficoll separation and cytospin preparations.
- Application of a panel of antibodies including Tdt, HLA-DR, CD19/CD20/CD22, CALLA (CD10), CD2, CD11C, and Ig heavy chains.
Main Results:
- 48 cases of acute lymphoblastic leukemia (ALL) were identified: 25 common pre-B ALL, 15 pre-B/NULL, and 8 T ALL.
- 24 cases were non-lymphoblastic (AML/AMML).
- Mean age varied by subtype (8 years for common ALL, 12 years for pre-B/NULL ALL, 36 years for AML/AMML). T-cell ALL presented in young adults with mediastinal masses.
Conclusions:
- IHC is effective for immunophenotyping acute leukemia subtypes.
- Distinct immunophenotypic profiles aid in differentiating ALL and AML.
- Age and clinical features correlate with specific leukemia subtypes.